Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Young Donor Plasma Transfusion and Age-Related Biomarkers
Authors not listed
Ambrosia LLC · 2016
Abstract
The purpose of the study is to evaluate the beneficial effects of infusions of plasma from young donors using blood biomarkers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Anonymous. (2016). Young Donor Plasma Transfusion and Age-Related Biomarkers. <em>Ambrosia LLC</em>. https://clinicaltrials.gov/study/NCT02803554
Vancouver
Anonymous. Young Donor Plasma Transfusion and Age-Related Biomarkers. Ambrosia LLC. 2016.
BibTeX
@misc{anon2016YoungD,
title = {Young Donor Plasma Transfusion and Age-Related Biomarkers},
author = {Anonymous},
journal = {Ambrosia LLC},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
AGE 2012
Open access · OA
The role of the T cell in age-related inflammation
Advances in experimental medicine and biology 2014
Citation only
Inflammation in Age-Related Macular Degeneration
Wake Forest University Health Sciences 2020
Open access · US-GOV
A Small-Scale Study to Explore the Safety and Feasibility of Allogeneic Young Plasma Infusion in Older Adults Experiencing Disability Across the Spectrum of Frailty Syndrome
The Journals of Gerontology Series A 2018
Open access · OA
Adipose Tissue Senescence and Inflammation in Aging is Reversed by the Young Milieu
Trends in Cardiovascular Medicine 2022
Preprint · OA
Myocardial ischemia-reperfusion injury and the influence of inflammation
Nature reviews. Immunology 2022
Preprint · OA